TR200002242T2 - 5-(2-İmidazolinilamino)-benzimidazol türevleri, bunların hazırlanması ve metabolik kararlılığı gelişmiş alfa-adrenoseptör agonistleri olarak kullanımları. - Google Patents
5-(2-İmidazolinilamino)-benzimidazol türevleri, bunların hazırlanması ve metabolik kararlılığı gelişmiş alfa-adrenoseptör agonistleri olarak kullanımları.Info
- Publication number
- TR200002242T2 TR200002242T2 TR2000/02242T TR200002242T TR200002242T2 TR 200002242 T2 TR200002242 T2 TR 200002242T2 TR 2000/02242 T TR2000/02242 T TR 2000/02242T TR 200002242 T TR200002242 T TR 200002242T TR 200002242 T2 TR200002242 T2 TR 200002242T2
- Authority
- TR
- Turkey
- Prior art keywords
- alpha
- imidazolinylamino
- preparation
- adrenoceptor agonists
- metabolic stability
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 3
- 102000015007 alpha-adrenergic receptor activity proteins Human genes 0.000 title abstract 2
- 108040006816 alpha-adrenergic receptor activity proteins Proteins 0.000 title abstract 2
- 230000002503 metabolic effect Effects 0.000 title 1
- JYQSIEABODGLIB-UHFFFAOYSA-N n-(4,5-dihydroimidazol-1-yl)-3h-benzimidazol-5-amine Chemical class C1=NCCN1NC1=CC=C(N=CN2)C2=C1 JYQSIEABODGLIB-UHFFFAOYSA-N 0.000 title 1
- 241000288906 Primates Species 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6676797P | 1997-11-24 | 1997-11-24 | |
| US6670097P | 1997-11-25 | 1997-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200002242T2 true TR200002242T2 (tr) | 2000-11-21 |
Family
ID=26747058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/02242T TR200002242T2 (tr) | 1997-11-24 | 1998-11-20 | 5-(2-İmidazolinilamino)-benzimidazol türevleri, bunların hazırlanması ve metabolik kararlılığı gelişmiş alfa-adrenoseptör agonistleri olarak kullanımları. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6486190B1 (enExample) |
| EP (1) | EP1037887B1 (enExample) |
| JP (1) | JP2001524478A (enExample) |
| KR (1) | KR20010032435A (enExample) |
| CN (1) | CN1284073A (enExample) |
| AT (1) | ATE271048T1 (enExample) |
| BR (1) | BR9815017A (enExample) |
| CA (1) | CA2311344C (enExample) |
| CO (1) | CO4970802A1 (enExample) |
| DE (1) | DE69825075T2 (enExample) |
| ES (1) | ES2223143T3 (enExample) |
| HU (1) | HUP0101469A3 (enExample) |
| IL (1) | IL136303A (enExample) |
| IN (1) | IN190809B (enExample) |
| NO (1) | NO20002655L (enExample) |
| NZ (1) | NZ504707A (enExample) |
| PE (1) | PE133699A1 (enExample) |
| PL (1) | PL340711A1 (enExample) |
| RU (1) | RU2193562C2 (enExample) |
| SK (1) | SK7792000A3 (enExample) |
| TR (1) | TR200002242T2 (enExample) |
| TW (1) | TW505642B (enExample) |
| WO (1) | WO1999026942A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2278016T3 (es) | 2001-04-09 | 2007-08-01 | Novartis Vaccines And Diagnostics, Inc. | Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r). |
| US7345065B2 (en) * | 2002-05-21 | 2008-03-18 | Allergan, Inc. | Methods and compositions for alleviating pain |
| FR2842422B1 (fr) * | 2002-07-16 | 2006-06-30 | Univ Aix Marseille Ii | Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations |
| RU2225401C1 (ru) * | 2002-09-16 | 2004-03-10 | Катаев Валерий Алексеевич | 5(6)-нитро-1-(1,1-диоксотиетанил-3)-2-хлорбензимидазол, проявляющий биологическую активность |
| US7268255B2 (en) * | 2003-02-20 | 2007-09-11 | Lonza Ag | Process for the preparation of N-substituted formamides |
| US20040167194A1 (en) * | 2003-02-20 | 2004-08-26 | Randall Jared Lynn | Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form |
| US20050020600A1 (en) * | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| US7812049B2 (en) | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| CN101426502A (zh) * | 2004-05-25 | 2009-05-06 | 桑斯罗萨医药发展公司 | 治疗或预防炎症性皮肤疾病的化合物、制剂及方法 |
| AU2006311577B2 (en) | 2005-11-09 | 2013-02-07 | Zalicus Inc. | Methods, compositions, and kits for the treatment of medical conditions |
| RU2306137C1 (ru) * | 2005-12-28 | 2007-09-20 | Денис Вячеславович Лисицын | Средство для профилактики и лечения гриппа |
| EP2819674A2 (en) * | 2012-02-27 | 2015-01-07 | Eye Therapies LLC | Compositions and methods for the treatment of migraine |
| WO2015073736A1 (en) | 2013-11-13 | 2015-05-21 | Arbor Pharmaceuticals, Llc | Methods and compositions for treating adhd |
| WO2017095905A1 (en) * | 2015-11-30 | 2017-06-08 | Flesher Gregory J | Compositions and methods for otologic prophylaxis and treatment |
| EA030197B1 (ru) * | 2016-03-22 | 2018-07-31 | Общество С Ограниченной Ответственностью "Рубикон" | Таблетированная форма противовирусного лекарственного средства |
| JP7163014B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 感冒薬 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4029792A (en) | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
| BE795970A (fr) | 1972-02-29 | 1973-08-27 | Pfizer | Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant |
| US4036976A (en) | 1973-04-05 | 1977-07-19 | Sandoz, Inc. | Substituted imidazolinylamino-indazoles |
| US4217356A (en) | 1975-08-22 | 1980-08-12 | Sandoz Ltd. | 2-Imidazolinylamino-2,1,3-benzothiadiazoles |
| US4398028A (en) | 1977-01-14 | 1983-08-09 | Sandoz Ltd. | Bicyclic heterocyclic amino derivatives |
| EP0086428B1 (en) | 1979-08-23 | 1987-07-29 | Beecham Group Plc | Antidiarrhoea veterinary composition, its production and oral doser containing it |
| WO1982000824A1 (en) | 1980-09-05 | 1982-03-18 | Geissmann F | 1h and 2h indazol derivatives and medicaments containing them |
| FR2638356A1 (fr) | 1988-10-28 | 1990-05-04 | Anben | Nouveaux derives de la 2-arylimino-imidazolidine pour diminuer la pression intra-oculaire et traiter le glaucome |
| US5180721A (en) | 1989-05-22 | 1993-01-19 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
| US5281591A (en) | 1989-05-22 | 1994-01-25 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
| US5231096A (en) | 1989-10-12 | 1993-07-27 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| US5021416A (en) | 1989-10-31 | 1991-06-04 | Allergan, Inc. | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
| US5091528A (en) | 1990-09-12 | 1992-02-25 | Allergan, Inc. | 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
| TW300219B (enExample) * | 1991-09-14 | 1997-03-11 | Hoechst Ag | |
| US5478858A (en) | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
| AU704972B2 (en) * | 1994-08-04 | 1999-05-13 | H. Lundbeck A/S | Novel benzimidazole derivatives |
| ID24081A (id) * | 1997-04-15 | 2000-07-06 | Procter & Gamble | Senyawa-senyawa 5-(2-imidazolinilamino) benzimidazol yang berguna sebagai agonis-agonis alfa-2-adrenoseptor |
-
1998
- 1998-11-20 US US09/554,698 patent/US6486190B1/en not_active Expired - Lifetime
- 1998-11-20 RU RU2000116269/04A patent/RU2193562C2/ru not_active IP Right Cessation
- 1998-11-20 EP EP98959512A patent/EP1037887B1/en not_active Expired - Lifetime
- 1998-11-20 BR BR9815017-0A patent/BR9815017A/pt not_active IP Right Cessation
- 1998-11-20 PL PL98340711A patent/PL340711A1/xx unknown
- 1998-11-20 IL IL13630398A patent/IL136303A/en not_active IP Right Cessation
- 1998-11-20 AT AT98959512T patent/ATE271048T1/de not_active IP Right Cessation
- 1998-11-20 CN CN98813286A patent/CN1284073A/zh active Pending
- 1998-11-20 DE DE69825075T patent/DE69825075T2/de not_active Expired - Lifetime
- 1998-11-20 SK SK779-2000A patent/SK7792000A3/sk unknown
- 1998-11-20 NZ NZ504707A patent/NZ504707A/xx unknown
- 1998-11-20 HU HU0101469A patent/HUP0101469A3/hu unknown
- 1998-11-20 TR TR2000/02242T patent/TR200002242T2/xx unknown
- 1998-11-20 CA CA002311344A patent/CA2311344C/en not_active Expired - Fee Related
- 1998-11-20 WO PCT/US1998/024694 patent/WO1999026942A1/en not_active Ceased
- 1998-11-20 JP JP2000522100A patent/JP2001524478A/ja not_active Withdrawn
- 1998-11-20 ES ES98959512T patent/ES2223143T3/es not_active Expired - Lifetime
- 1998-11-20 KR KR1020007005675A patent/KR20010032435A/ko not_active Abandoned
- 1998-11-25 CO CO98069637A patent/CO4970802A1/es unknown
- 1998-11-25 PE PE1998001146A patent/PE133699A1/es not_active Application Discontinuation
- 1998-11-26 IN IN3539DE1998 patent/IN190809B/en unknown
-
1999
- 1999-02-10 TW TW087119586A patent/TW505642B/zh active
-
2000
- 2000-05-24 NO NO20002655A patent/NO20002655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010032435A (ko) | 2001-04-25 |
| JP2001524478A (ja) | 2001-12-04 |
| EP1037887B1 (en) | 2004-07-14 |
| CA2311344A1 (en) | 1999-06-03 |
| IN190809B (enExample) | 2003-08-23 |
| IL136303A (en) | 2004-02-08 |
| NZ504707A (en) | 2002-11-26 |
| CN1284073A (zh) | 2001-02-14 |
| US6486190B1 (en) | 2002-11-26 |
| PE133699A1 (es) | 2000-03-05 |
| NO20002655D0 (no) | 2000-05-24 |
| IL136303A0 (en) | 2001-05-20 |
| HUP0101469A2 (hu) | 2001-10-28 |
| EP1037887A1 (en) | 2000-09-27 |
| HUP0101469A3 (en) | 2003-01-28 |
| WO1999026942A8 (en) | 2000-08-03 |
| WO1999026942A1 (en) | 1999-06-03 |
| NO20002655L (no) | 2000-07-24 |
| CO4970802A1 (es) | 2000-11-07 |
| PL340711A1 (en) | 2001-02-26 |
| SK7792000A3 (en) | 2001-01-18 |
| DE69825075D1 (de) | 2004-08-19 |
| ES2223143T3 (es) | 2005-02-16 |
| ATE271048T1 (de) | 2004-07-15 |
| BR9815017A (pt) | 2001-09-11 |
| RU2193562C2 (ru) | 2002-11-27 |
| DE69825075T2 (de) | 2005-08-25 |
| CA2311344C (en) | 2006-02-07 |
| TW505642B (en) | 2002-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200002242T2 (tr) | 5-(2-İmidazolinilamino)-benzimidazol türevleri, bunların hazırlanması ve metabolik kararlılığı gelişmiş alfa-adrenoseptör agonistleri olarak kullanımları. | |
| PE20040165A1 (es) | Uso de analogos del benzimidazol en el tratamiento de la proliferacion celular | |
| TR200200588T2 (tr) | N-pirazol A2A reseptör agonistleri | |
| ATE244715T1 (de) | Azol-verbindungen, ihre herstellung und ihre verwendung | |
| ES2196072T3 (es) | Empleo de compuestos heterociclicos como ligandos de dopamina-d3. | |
| TR200402069T4 (tr) | Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması | |
| DE69928226D1 (de) | Chemokin rezeptor antagonisten und verwndung | |
| EA200401284A1 (ru) | Замещённые бензазолы и их применение в качестве ингибиторов киназы raf | |
| CR10167A (es) | "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor" | |
| CY1112377T1 (el) | Μεθοδος και συνθεσεις για τη θεραπευτικη aντιμετωπιση των αιματολογικων κακοηθειων | |
| PE20020637A1 (es) | Derivados de 5-oxo-pirrolidina como agonistas de prostaglandinas | |
| ATE430743T1 (de) | Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken | |
| ATE366602T1 (de) | Festförmiges färbemittel für keratinfasern | |
| MX9303469A (es) | Derivados de benzimidazol, procedimiento para su preparacion, composicion farmaceutica que los contiene y procedimiento para preparar de la misma. | |
| MX2009010567A (es) | Derivados de imidazolidinona. | |
| MA39043B1 (fr) | Dérivés de purine substitués en positions 2 et 6, et leur utilisation dans le traitement des désordres prolifératifs | |
| EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
| UY26226A1 (es) | 'derivados de aminopirrolidina heterocíclica como agentes melatonergicos'.- ley 17.164.- | |
| TR200401716T4 (tr) | Yeni üç yerdeğiştirme gruplu fenil türevleri ve analogları | |
| IS6426A (is) | Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni | |
| DK2886D0 (da) | Dopamin-beta-hydroxylaseinhibitorer | |
| PE20021153A1 (es) | 5-[2-BUTOXI-5-(1-HIDROXIETIL)-3-PIRIDINIL]-3-ETIL-2-(1-ETIL-3-AZETIDINIL)-2,6-DIHIDRO-7H-PIRAZOLO[4,3-d]PIRIMIDIN-7-ONA COMO INHIBIDORES DE FOSFODIESTERASAS DE GUANOSIN 3',5'-MONOFOSFATO CICLICO | |
| TR199802033T2 (xx) | Böcek öldürücü siprodinil ve miklobutanil bileşimi. | |
| EA200100853A1 (ru) | Резорциновая композиция | |
| UY26648A1 (es) | Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada |